Tag:
RotaTeq
Latest Headlines
Latest Headlines
U.K. vaccine expansion a boon for GSK and Merck
Sales of GlaxoSmithKline's rotavirus vaccine Rotarix and Merck's shingles vaccine Zostavax will be buoyed by their inclusion on the U.K. national immunization schedule.
GSK's rotavirus vaccine selected for British program
British health officials selected GlaxoSmithKline's Rotarix vaccine for the country's first routine rotavirus immunization program.
20 Top-selling Vaccines -- H1 2012
As H1 came to a close, FierceVaccines decided to take a look at which prophylactic vaccines flew off the shelves--and which companies made the sales.
The 20 top-selling vaccines in H1 2012
As H1 came to a close, FierceVaccines decided to take a look at which prophylactic vaccines flew off the shelves--and which companies made the sales. Take a look at the full list >>
Merck's RotaTeq will be saving lives in Rwanda
Rwanda's government has launched a national rotavirus vaccination program using Merck's RotaTeq oral rotavirus vaccine. The program will include all infants in the country, meaning that over 100,000 children will get the vaccine before the end of 2012.
GAVI signs deal for diarrhea vax for world's poorest
The deal cuts the price for the vaccines 67 percent and means vaccines for 70 million children in the world's 40 poorest countries by 2016.
UPDATED: Academics' oral stomach flu vax could save lives
A new oral vaccine from Australia could help to cut deaths from rotavirus infections, in the developing as well as the developed world.
Merck's RotaTeq not linked with bowel problems
In the past, vaccines against rotavirus, an infection causing severe diarrhea, have been linked with serious bowel problems and blockages in infants, but a large-scale study of over three-quarters of
Merck plans copy of Rotateq in India
MSD Wellcome Trust Hilleman Laboratories, set up in India last year with support from Merck, will attempt to make a copy of the company's Rotateq vaccine for the prevention of diarrhea. Researchers
FDA takes brakes off GSK's Rotarix
Rotavirus vaccines are in the clear. The FDA has decreed that both GlaxoSmithKline's ( NYSE: GSK ) Rotarix and Merck's ( NYSE: MRK ) Rotateq are safe despite their contamination with DNA from a pig virus
